Afinitor Disperz 3 MG Tablet for Oral Suspension

RxCUI: 1310144
RxNorm name: Afinitor Disperz 3 MG Tablet for Oral Suspension
Display name: Afinitor Disperz 3 MG Tablet for Oral Suspension
Full name: Afinitor Disperz 3 MG Tablet for Oral Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Afinitor	EVEROLIMUS	Novartis Pharmaceuticals Corporation	2150f73a-179b-4afc-b8ce-67c85cc72f04	2026-06-01	Warnings, Adverse reactions	Exact identifier rxcui: 1310144

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
2150f73a-179b-4afc-b8ce-67c85cc72f04	AFINITOR DISPERZ 3 MG Tablet for Oral Suspension [PSN] · everolimus 3 MG Tablet for Oral Suspension [Afinitor] [SBD] · Afinitor Disperz 3 MG Tablet for Oral Suspension [SY]	3	66	These highlights do not include all the information needed to use AFINITOR/AFINITOR DISPERZ safely and effectively. See full prescribing information for AFINITOR/AFINITOR DISPERZ. AFINITOR ® (everolimus) tablets, for oral use AFINITOR DISPERZ ® (everolimus tablets for oral suspension) Initial U.S. Approval: 2009	20260212